All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


  • Medicines Control Agency issues further warning on St John's Wort

    Keith Alcorn | 05 March 2001

    The UK's Medicines Control Agency has issued guidance for doctors and people with HIV following the publication of a report showing that the popular herbal anti-depressant St John's Wort can ...

  • More tricky drug interactions: fine tuning HAART

    Keith Alcorn | 05 March 2001

    Highlights from the First International Workshop on Clinical Pharmacology of HIV Therapy, Noordwijk, The Netherlands, March 30-31, 2000. Using efavirenz with bid IDV/RTV 800/100mg ABT-378/r with other PIs Amprenavir and ritonavir Amprenavir/ritonavir and efavirenz Saquinavir ...

  • PI-dropping studies: still little impact on body fat changes

    Keith Alcorn | 05 March 2001

    Switching from a protease inhibitor to an NNRTI or abacavir yields inconsistent results when the aim is the reduction of PI-related side effects such as lipid and body fat disorders, ...

  • New US guidelines on hepatitis C testing and counselling

    Anon | 05 March 2001

    The US Centers for Disease Control have published expert guidelines on hepatitis C testing and counselling, with the warning that approximately 3.9 million Americans are already infected. Research published in ...

  • d4T & fat wasting - more evidence

    Keith Alcorn | 05 March 2001

    Further evidence that people who receive long-term treatment with d4T are more likely to suffer fat wasting compared with people receiving AZT was presented this week at the Eighth Annual ...

  • Preventing mother-to-baby transmission in South Africa

    Anon | 05 March 2001

    A range of measures designed to prevent transmission of HIV from mother to baby in South African women constitute cost effective healthcare strategy according to a research team in Johannesburg. Using ...

  • 39th ICAAC opens in San Francisco

    Anna Poppa | 05 March 2001

    The 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) has opened in a scorching San Francisco. This annual meeting of the American Society for Microbiology is set to be ...

  • HAART for Africa would cost rich world taxpayers $2 a year

    Keith Alcorn | 05 March 2001

    Dr Jeffery Sachs, Professor of International Development at Harvard University, considered by the New York Times to be the most important economist in the world, launched a wide ranging attack ...

  • IAS guidelines: US/international panel sticks to early treatment approach

    Keith Alcorn | 05 March 2001

    The International AIDS Society will continue to recommend HIV treatment for asymptomatic individuals with CD4+ cell counts between 350 and 500 and viral load above 5,000 copies, in contrast to ...

  • Treatment interruptions on hydroxyurea slow viral rebound

    Keith Alcorn | 05 March 2001

    Interrupting a hydroxyurea-containing HAART regimen may not lead to the same degree of viral rebound as seen with other structured treatment interruptions, according to Franco Lori and colleagues at the ...

NAM news and opinions


hiv & aids news selected from other sources

  • Side-effects
    Long-term efavirenz linked to worse neurocognitive function in US CHARTER group
    EATG / NATAP | 07 March 2013

    Long-term treatment with an efavirenz-based regimen correlated with worse neurocognitive function than did treatment with lopinavir/ritonavir, according to results of a retrospective case-control comparison within the US CHARTER cohort.

  • New and experimental hepatitis C treatment
    Four in Five People With HIV and Hep C on Faldaprevir Achieve Early Treatment Success
    AIDSMeds | 07 March 2013

    Interim results from a trial of the hep C drug faldaprevir, given to people coinfected with hep C and HIV, have shown an 80 percent early success rate.

  • New and experimental hepatitis C treatment
    Copy of Four in Five People With HIV and Hep C on Faldaprevir Achieve Early Treatment Success
    Kaiser Daily Global Health Policy Report | 07 March 2013

    Interim results from a trial of the hep C drug faldaprevir, given to people coinfected with hep C and HIV, have shown an 80 percent early success rate.

  • Diabetes
    Every year of statin therapy boosts diabetes risk 10% in US HIV cohort
    EATG / NATAP | 07 March 2013

    Every year of treatment with lipid-lowering statins boosted the risk of diabetes 10% in members of the HIV Outpatient Study (HOPS). The results confirm an earlier finding of self-reported diabetes associated with statin use in a large general-population study of US postmenopausal women, but the impact of statins seemed more modest in the HOPS analysis.

  • People who inject drugs
    Heroin and crack use 'plummeting'
    BBC Health | 06 March 2013

    The number of heroin and crack users in England is "plummeting", according to the National Treatment Agency for Substance Misuse.

  • Adherence
    CROI 2013: The VOICE Results—A Social Scientist’s Perspective
    BETA blog | 06 March 2013

    To social scientist Judith D. Auerbach, PhD, a consultant to the NIH Office of AIDS Research and San Francisco AIDS Foundation, the VOICE results raise a number of questions—but not the ones you might think.

  • Finance and funding
    HIV 'cure' at risk from budget cuts
    CNN | 06 March 2013

    The automatic cuts in federal spending known as sequestration could take a bite out of crucial medical research, such as the recently unveiled study in which a toddler was cured of HIV.

  • Cardiovascular disease
    HIV linked to higher chance of heart attack
    Reuters | 06 March 2013

    People with HIV are almost 50 percent more likely to have a heart attack than those who aren't infected with the virus - even after taking into account their other health risks, according to a new study.

  • The search for a cure
    Reports of 'HIV cure' are premature
    NHS Choices | 05 March 2013

    Global news coverage has been dominated by the potentially groundbreaking news that a child born with HIV appears to have been ‘cured’ of the infection. The findings do not mean that a complete cure for HIV has been discovered.

  • Retention and linkage to care
    Falling Through the Cracks
    Poz | 05 March 2013

    We can strengthen two of the weakest links in the U.S. health care chain for people with HIV/AIDS—linking people to care and retaining them in care—but doing so requires a collective approach.

Conference news

Coming soon: news from the 22nd International AIDS Conference (AIDS 2018).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

New EUROBulletin

Read the June edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.